Emcure Pharmaceuticals Limited

Nifty500

EMCURE-EQ: NSEBSE: 24398

Emcure Pharmaceuticals Limited (EMCURE-EQ) live share price today at NSE / BSE

INR 1,909.80

-22.10 (-1.14%)1 Day

Thu, 17 Sept 2026, 02:27 PM

About EMCURE-EQ

Emcure Pharmaceuticals Ltd is a prominent Indian pharmaceutical company specializing in the development, manufacturing, and global marketing of a wide range of pharmaceutical products. Headquartered in Pune, Maharashtra, Emcure’s operations encompass formulations, biotechnology, and active pharmaceutical ingredients (APIs), with a diversified portfolio spanning therapeutic areas such as oncology, cardiology, anti-infectives, HIV antivirals, gynecology, and nephrology. The company operates through a mix of domestic sales and global exports, with a presence in over 70 countries including significant markets in North America, Europe, Asia, and Africa.

52 Week Range

HighINR 2,048.00

LowINR 1,260.00

Current Signal

red

Open

INR 1,913.20

High

INR 1,940.40

Low

INR 1,891.60

Prev. Close

INR 1,931.90

Volume

1,36,884

Avg. Volume (7D)

1,63,623

Avg. Volume (10D)

1,65,024

Latest Signal

Sell

Sell Price

INR 1943.9

Close Price

INR 1931.9

Change

2.69%

Signal Date

2026-09-16

Hold

Pattern

Doji

Company Snapshot

CIN	L24231PN1981PLC024251
Industry	Pharmaceuticals
Market Lot	1
Impact Cost	0.14%
Listing Date	09 Jul 2024
BC Record Date	RD 14/08/2025
Registered Address	Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi,
Auditor	B S R & Co. LLP

Registrar

Name

MUFG Intime India Pvt. Ltd

Telephone

810 8114949

Website

www.in.mpms.mufg.com

Shareholding Pattern

Quarterly filing · 30 Jun 2026

Promoter & Promoter Group77.83%

Non-Institutions10.18%

Domestic Institutions1.34%

Foreign Institutions0.00%

Board of Directors

Mr.Berjis Minoo DesaiNon-Executive - Non Independent Director-Chairperson

Mr.Chetan Rajendra SharmaCompany Secretary and Compliance Officer

Mr.Mukund Keshao GurjarExecutive Director

Mr.Palamadai Sundararajan JayakumarNon-Executive - Independent Director

Mr.Samit Satish MehtaExecutive Director

Mr.Satish Ramanlal MehtaExecutive Director-CEO-MD

Mr.Shailesh Kripalu AyyangarNon-Executive - Independent Director

Mr.Sunil Rajanikant MehtaExecutive Director

Mr.Tajuddin Sabir ShaikhChief Financial Officer

Mr.Vijay Keshav GokhaleNon-Executive - Independent Director

Mrs.Namita Vikas ThaparExecutive Director

Mrs.Vidya Rajiv YeravdekarNon-Executive - Independent Director

Today Share Price

Emcure Pharmaceuticals Limited

Particulars	Details
Opening Price	INR 1,913.20
Previous Closing Price	INR 1,931.90
Volume of Emcure Pharmaceuticals Limited	1,36,884
Value of Share	—

Today NSE Share Price

Emcure Pharmaceuticals Limited

Particulars	Details
Live Share Price NSE India	INR 1,909.80
Previous Closing Price	INR 1,931.90
Open Price	INR 1,913.20
High	INR 1,940.40
Low	INR 1,891.60

Today BSE Share Price

Emcure Pharmaceuticals Limited

Particulars	Details
Live Share Price BSE India	INR 1,909.80
Previous Closing Price	INR 1,931.90
Open Price	INR 1,913.20
High	INR 1,940.40
Low	INR 1,891.60

Emcure Pharmaceuticals Limited

With a strong emphasis on research and development, Emcure maintains multiple manufacturing and research facilities accredited by stringent global regulatory agencies like the US FDA, UK MHRA, and WHO. The company’s strategic focus includes affordable healthcare solutions, continual product innovation, and substantial investments in biotechnological advancements, allowing it to address unmet medical needs and scale in regulated and growth markets.

Frequently Asked Questions – StockYaari Stock Page

Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.

Final Thoughts

Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.